BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease

European Respiratory Journal

Volumn 24, Issue 3, 2004, Pages 371-374

  Roberts, K E ^a   McElroy, J J ^a   Wong, W P K ^a   Yen, E ^a   Widlitz, A ^a   Barst, R J ^a   Knowles, J A ^a,b   Morse, J H ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Bone morphogenetic protein; Congenital heart defects; Eisenmenger syndrome; Pulmonary hypertension; Receptor 2 mutations

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AORTOPULMONARY SEPTAL DEFECT; ARTICLE; ATRIOVENTRICULAR CANAL; BLOOD VESSEL OCCLUSION; CHILD; COHORT ANALYSIS; COMORBIDITY; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LUNG ARTERIOVENOUS SHUNT; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADULT; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CHILD; COHORT STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; MUTATION, MISSENSE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, DNA;

EID: 4544386270     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00018604     Document Type: Article

References (24)

1. Rich S. ed. Primary pulmonary hypertension: executive summary from the World Symposium-Primary Pulmonary Hypertension. Available at www.who.int/ncd/cvd/.pph.html; last accessed: 11 July 2001.
2. Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67: 737-744.
3. Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000; 26: 81-84.
4. Machado RD, Pauciulo MW, Thomson JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001; 68: 92-102.
5. Thomson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-B family. J Med Genet 2000; 37: 741-745.
6. Humbert M, Deng Z, Simonneau G, et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Resp J 2002; 20: 518-523.
7. Nunes H, Humbert M, Sitbon O, et al. Declining mortality from HIV-associated pulmonary arterial hypertension with combined use of highly active anti-retroviral therapy and long-term epoprostenol infusion. Am J Resp Crit Care Med 2002; 20: 518-523.
8. Morse J, Barst R, Horn E, et al. Pulmonary hypertension in scleroderma spectrum of disease: Lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 2002; 11: 2379-2381.
9. Eisenmenger V. Z Klin Med 1897; 32, Suppl., 1.
10. Barst RJ. Primary pulmonary hypertension. In: Friedman WF, ed. Proceedings of the National Heart, Lung, and Blood Institute pediatric cardiology workshop: pulmonary hypertension. Pediatric Res 1986; 20: 816-817.
11. Schneider MD, Gaussin V, Lyons KM. Tempting fate: BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev 2003; 14: 1-4.
12. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-1594.
13. Gaussin V, Van de PT, Mishina Y, et al. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci USA 2002; 99: 2878-2883.
14. Pierpont ME, Markwald RR, Lin AE. Genetic aspects of atrioventricular septal defects. Am J Med Genet 2000; 97: 289-296.
15. Delot EC, Bahamonde ME, Zhao M, Lyons KM. Development and Disease. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 2003; 130: 209-220.
16. Jiao K, Kulessa H, Tompkins K, et al. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev 2003; 17: 2362-2367.
17. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999; 99: 1197-1208.
18. Newman JH, Fanburg BL, Archer SL, et al. Pulmonary arterial hypertension: future directions report of an NHLBI/ORD workshop. Circulation 2004 (in press).
19. Voelkel NF, Cool C, Lee SD, et al. Primary pulmonary hypertension between inflammation and cancer. Chest 1998; 114: 225S-230S.
20. Beppu H, Kawabata M, Hamamoto T, et al. BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 2000; 221: 249-258.
21. Bleiden LC, Moller JH. Small ventricular septal defect associated with severe pulmonary hypertension. Br Heart J 1984; 52: 117-118.
22. Bisset GS, III, Hirschfeld SS. Severe pulmonary hypertension associated with a small ventricular septal defect. Circulation 1983; 67: 470-473.
23. Haworth SG. Pulmonary vascular disease in secundum atrial septal defect in childhood. Am J Cardiol 1983; 51: 265-272.
24. Morse JH, Barst RJ, Fotino M. Familial pulmonary hypertension: immunogetic findings in four Caucasian kindreds. Am Rev Respir Dis 1992; 145: 787-792.